CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 710,000 shares at $14.00 ($9,940,000)
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 1,785,000 shares at $14.00 ($24,990,000)
- 4 Conversion See Remarks acquired 4,552 shares (conversion)
- 4 Conversion Director acquired 139,672 shares (conversion)
- 8-K Event Bylaws or fiscal year change
- 424B4 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 4 Grant or award See Remarks acquired 26,250 shares (grant or award)
- 4 Grant or award See Remarks acquired 74,357 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 17,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 26,250 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Business Officer acquired 8,750 shares (grant or award)
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
Page 17 of 20 · 383 filings